Outsourcing

Nov 16, 2017
By BioPharm International Editors
Germany tops quality ranking in the inaugural CPhI Global Pharma Index.
Nov 01, 2017
BioPharm International
Recent acquisitions are creating CDMOs with scale that rivals global bio/pharma.
Oct 25, 2017
By BioPharm International Editors
The M&A advisory firm has developed an interactive map of manufacturing sites to give insight into the market size of global manufacturing.
Oct 14, 2017
By BioPharm International Editors
Samsung BioLogics’ second facility adds 152,000 L of mAb drug substance capacity.
Oct 01, 2017
BioPharm International
Mergers and acquisitions are positive for the CDMO industry, but there is a downside.
Sep 26, 2017
By BioPharm International Editors
ADC Bio announces plans to expand into clinical and commercial drug manufacturing for ADCs.
Sep 21, 2017
By BioPharm International Editors
Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.
Sep 19, 2017
By BioPharm International Editors
The acquisition adds to Catalent’s capabilities in biologics development, analytical services, manufacturing, and finished product supply.
Sep 01, 2017
BioPharm International
Innovation speeds discovery, drives down costs, and improves productivity.
Aug 01, 2017
BioPharm International
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
native1_300x100
lorem ipsum